Explore our comprehensive coverage of alzheimer's, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
AI and Google have developed advanced diagnostic tools that can detect diseases like lung cancer and Alzheimer's with greater accuracy and speed than ...
Read Full Story →
PoliticsIn a historic June 2026 decision, the FDA approved NeuroClear, the first CRISPR-based gene therapy t...
HealthcareIn a historic June 2026 decision, the FDA approved NeuroClear, the first CRISPR-based gene therapy t...
PoliticsThe FDA has approved NeuroEdit-AD, the first in vivo CRISPR gene therapy for Alzheimer's disease. Th...
GadgetsSenolytic drugs like dasatinib and quercetin are entering advanced clinical trials in 2026, targetin...
GadgetsThe 2026 Alzheimer's pipeline features 192 clinical trials, highlighted by the FDA approval of subcu...
HealthcareBiogen and Eisai report Phase 3 success for NeuroClear, a bispecific antibody that crosses the blood...
